NFA
CALA

Nationwide Fund Advisors’s Calithera Biosciences, Inc CALA Stock Holding History

Nationwide Fund Advisors’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-2,237
Closed -$705K – 2467
2017
Q3 		$705K Hold
2,237
– – ﹤0.01% 1997
2017
Q2 		$664K Buy
2,237
+1,672
+296% +$447K ﹤0.01% 2027
2017
Q1 		$131K Buy
+565
New +$97.6K ﹤0.01% 2760
2016
Q2 		– Sell
-4,063
Closed -$462K – 3322
2016
Q1 		$462K Buy
4,063
+105
+3% +$11.9K ﹤0.01% 2142
2015
Q4 		$606K Buy
3,958
+3,600
+1,006% +$540K ﹤0.01% 2010
2015
Q3 		$39K Hold
358
– – ﹤0.01% 3062
2015
Q2 		$51K Buy
358
+61
+21% +$14.1K ﹤0.01% 3101
2015
Q1 		$98K Hold
297
– – ﹤0.01% 2967
2014
Q4 		$120K Buy
+297
New +$77.6K ﹤0.01% 2858

Other funds holding CALA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
AC
Ascend Capital Orinda, California $1.99B AUM 10.36% 1-Year Est. Return

Nationwide Fund Advisors's CALA Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Calithera Biosciences, Inc (CALA) in Q4 2017, closing a stake of 2,237 shares — an estimated $705K sold.

Nationwide Fund Advisors first reported a position in CALA in Q4 2014 and held it in 9 quarters. The position peaked at $705K in Q3 2017. 112 funds tracked by Wall St. Rank hold CALA as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Calithera Biosciences, Inc position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 2,237 Calithera Biosciences, Inc shares in Q4 2017, an estimated $705K.
  • Nationwide Fund Advisors first reported a position in Calithera Biosciences, Inc in Q4 2014 and held it in 9 quarters.
  • Nationwide Fund Advisors's Calithera Biosciences, Inc position peaked at $705K in Q3 2017.
  • 112 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.